Danielle Murashige

Danielle Murashige

Auto-generated profile, based on publicly available information

Danielle Murashige

Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.S.M., Z.A.).

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2020 in Science
Verified
Journal Article
Closed access
DMDanielle Murashige
Danielle Murashige
Cholsoon jangCholsoon jang
Cholsoon jang
MNMichael Neinast
Michael Neinast
JEJonathan J. Edwards
Jonathan J. Edwards
ACAlexis Cowan
Alexis Cowan
ZAZolt Arany
Zolt Arany
Metabolomics, at the heart: With heart failure a leading cause of death, a better understanding of metabolic function in the heart is a welcome advance. Murashige et al. measured more than 270 metabolites using liquid chromatography–mass spectrometry in human blood samples taken from an artery entering the heart and from a vein leaving it. Differences thus reflected the metabolic processes at work in the heart. Their results confirmed that hearts voraciously consume fatty acids. Hearts secreted, rather than consumed, amino acids, thus revealing active proteolysis. In patients with heart failure, ketone and lactate consumption increased, as did proteolysis. These findings could lead to strategies for fighting heart disease by altering metabolism. Science , this issue p. 364

11 October 2022 in Cell Metabolism
Verified
Journal Article
Closed access
DMDanielle Murashige
Danielle Murashige
JJJae Woo Jung
Jae Woo Jung
MNMichael D. Neinast
Michael D. Neinast
MLMichael G. Levin
Michael G. Levin
QCQingwei Chu
Qingwei Chu
ZAZoltan Arany
Zoltan Arany

18 February 2025 in Circulation
Verified
Journal Article
Closed access
MTMaya Talukdar
Maya Talukdar
LCLukáš Chmátal
Lukáš Chmátal
LMLinyong Mao
Linyong Mao
DRDaniel Reichart
Daniel Reichart
DMDanielle S. Murashige
Danielle S. Murashige
DPDavid C. Page
David C. Page

2 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
MTMaya Talukdar
Maya Talukdar
LCLukáš Chmátal
Lukáš Chmátal
LMLinyong Mao
Linyong Mao
DRDaniel Reichart
Daniel Reichart
DMDanielle Murashige
Danielle Murashige
DPDavid C. Page
David C. Page
Human females and males differ in cardiac physiology and pathology, even after controlling for sex differences in anthropometrics, lifestyle, and environment. For example, females and males differ in cardiac stroke volume and ventricular thickness, and they exhibit different rates and symptoms of cardiovascular disease. Less is understood about molecular differences in female and male hearts, such as sex differences in gene expression. Here we present an integrative framework utilizing bulk and single-nucleus RNA-sequencing data to study sex differences in the cardiac transcriptome. We show that genes of the fatty acid oxidation (FAO) pathway, the primary source of energy in the heart, are expressed more highly in healthy female than in healthy male hearts. We demonstrate that this sex difference is due to cardiomyocyte-specific, female-biased expression of FAO genes and cannot be explained by sex differences in cardiac cellular composition or number of mitochondria, where FAO takes place. Finally, we observe increased cardiac flux and energetic utilization of free fatty acids in female compared to male hearts. Overall, our results demonstrate that male and female human hearts exhibit fundamental differences in metabolism that likely contribute to sex differences in cardiac physiology and pathology.